Toxic shock syndrome: Difference between revisions

No edit summary
No edit summary
Line 10: Line 10:
Also effect neutrophil chemotaxis suppression, blockage of reticuloendothelial system
Also effect neutrophil chemotaxis suppression, blockage of reticuloendothelial system


==Risk Factors==
===Risk Factors===
#postop patients
*postop patients
#[[Epistaxis|nasal packing]]
*[[Epistaxis|nasal packing]]
#abscess
*abscess
#burns
*burns
#tampons
*tampons
#IUDs
*IUDs


==Differential Diagnosis==
==Differential Diagnosis==
Line 22: Line 22:


==Evaluation==
==Evaluation==
#Fever: temperature >38.9°C
*Fever: temperature >38.9°C
#Rash: diffuse macular erythroderma
*Rash: diffuse macular erythroderma
#Hypotension: systolic blood pressure <90 mm Hg (adults) or <5th percentile for age (children younger than 16 years), or orthostatic hypotension, dizziness, or syncope
*Hypotension: systolic blood pressure <90 mm Hg (adults) or <5th percentile for age (children younger than 16 years), or orthostatic hypotension, dizziness, or syncope
#Multisystem dysfunction: at least 3:
*Multisystem dysfunction: at least 3:
##Gastrointestinal: vomiting or diarrhea at onset of illness
**Gastrointestinal: vomiting or diarrhea at onset of illness
##Muscular: severe myalgias, or serum creatine phosphokinase level (CPK) greater than twice the upper limit of normal
**Muscular: severe myalgias, or serum creatine phosphokinase level (CPK) greater than twice the upper limit of normal
##Mucous membranes: vaginal, oropharyngeal, or conjunctival hyperemia
**Mucous membranes: vaginal, oropharyngeal, or conjunctival hyperemia
##Renal: blood urea nitrogen or creatinine level greater than twice the upper limit of normal, or pyuria (5 leukocytes per high-power field), in the absence of urinary tract infection
**Renal: blood urea nitrogen or creatinine level greater than twice the upper limit of normal, or pyuria (5 leukocytes per high-power field), in the absence of urinary tract infection
##Hepatic: total serum bilirubin or transaminase level greater than twice the upper limit of normal
**Hepatic: total serum bilirubin or transaminase level greater than twice the upper limit of normal
##Hematologic: platelets<100,000/L
**Hematologic: platelets<100,000/L
##Central nervous system: disorientation or alteration in consciousness but no focal neurologic signs at a time when fever and hypotension are absent.
**Central nervous system: disorientation or alteration in consciousness but no focal neurologic signs at a time when fever and hypotension are absent.
#Desquamation: One to 2 weeks after the onset of illness (typically palms and soles)
*Desquamation: One to 2 weeks after the onset of illness (typically palms and soles)
#Evidence against an alternative diagnosis: If obtained:
*Evidence against an alternative diagnosis: If obtained:
##negative culture results for blood, throat, or cerebrospinal fluid
**negative culture results for blood, throat, or cerebrospinal fluid
##absence of an increase in antibody titers to the agents of leptospirosis, measles, or Rocky Mountain spotted fever.
**absence of an increase in antibody titers to the agents of leptospirosis, measles, or Rocky Mountain spotted fever.


^“Confirmed” case meets all 6 criteria; “probable” case meets 5 of the 6.
^“Confirmed” case meets all 6 criteria; “probable” case meets 5 of the 6.
Line 43: Line 43:


==Management==
==Management==
#Abx, including Clindamycin, Vanc
*Abx, including Clindamycin, Vanc
#Supportive, pressors often
*Supportive, pressors often


==References==
==References==

Revision as of 12:49, 30 July 2016

Background

Epidemiology

1-2/100,000 cases/yr

Etiology

S. aureus strain that produces toxic shock syndrome toxin-1 (superantigen)

Superantigens stimulate T-cell proliferation independent of antigen-specific binding --> massive cytokine production

Also effect neutrophil chemotaxis suppression, blockage of reticuloendothelial system

Risk Factors

Differential Diagnosis

Erythematous rash

Evaluation

  • Fever: temperature >38.9°C
  • Rash: diffuse macular erythroderma
  • Hypotension: systolic blood pressure <90 mm Hg (adults) or <5th percentile for age (children younger than 16 years), or orthostatic hypotension, dizziness, or syncope
  • Multisystem dysfunction: at least 3:
    • Gastrointestinal: vomiting or diarrhea at onset of illness
    • Muscular: severe myalgias, or serum creatine phosphokinase level (CPK) greater than twice the upper limit of normal
    • Mucous membranes: vaginal, oropharyngeal, or conjunctival hyperemia
    • Renal: blood urea nitrogen or creatinine level greater than twice the upper limit of normal, or pyuria (5 leukocytes per high-power field), in the absence of urinary tract infection
    • Hepatic: total serum bilirubin or transaminase level greater than twice the upper limit of normal
    • Hematologic: platelets<100,000/L
    • Central nervous system: disorientation or alteration in consciousness but no focal neurologic signs at a time when fever and hypotension are absent.
  • Desquamation: One to 2 weeks after the onset of illness (typically palms and soles)
  • Evidence against an alternative diagnosis: If obtained:
    • negative culture results for blood, throat, or cerebrospinal fluid
    • absence of an increase in antibody titers to the agents of leptospirosis, measles, or Rocky Mountain spotted fever.

^“Confirmed” case meets all 6 criteria; “probable” case meets 5 of the 6.

†Blood culture may be positive for S aureus.

Management

  • Abx, including Clindamycin, Vanc
  • Supportive, pressors often

References

AnnalsofEM Nov 2009